Perry AS, Dooley EE, Master H, Spartano NL, Brittain EL, Pettee GK. Physical activity over the lifecourse and cardiovascular disease. Circ Res. 2023;132(12):1725–40.
Article CAS PubMed Google Scholar
Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2019). Hypertens Res. 2019;42(9):1235–481.
Roth GA, Mensah GA, Fuster V. The Global burden of cardiovascular diseases and risks: a compass for global action. J Am Coll Cardiol. 2020;76(25):2980–1.
Article CAS PubMed Google Scholar
Wong ND, Sattar N. Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention. Nat Rev Cardiol. 2023;20(10):685–95.
Novak M, Mucsi I, Rhee CM, Streja E, Lu JL, Kalantar-Zadeh K, et al. Increased risk of incident chronic kidney disease, cardiovascular disease, and mortality in patients with diabetes with comorbid depression. Diabetes Care. 2016;39(11):1940–7.
Article PubMed PubMed Central Google Scholar
DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214–23.
Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol. 1979;236(6):E667–77.
Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.
Vasques ACJ, Novaes FS, de Oliveira MdS, Souza JRM, Yamanaka A, Pareja JC, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98-100.
Article CAS PubMed Google Scholar
Sheng G, Lu S, Xie Q, Peng N, Kuang M, Zou Y. The usefulness of obesity and lipid-related indices to predict the presence of non-alcoholic fatty liver disease. Lipid Health Dis. 2021;20(1):134.
Juonala M, Magnussen CG, Berenson GS, Venn A, Burns TL, Sabin MA, et al. Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med. 2011;365(20):1876–85.
Article CAS PubMed Google Scholar
Wahrenberg H, Hertel K, Leijonhufvud B-M, Persson L-G, Toft E, Arner P. Use of waist circumference to predict insulin resistance: retrospective study. BMJ. 2005;330(7504):1363–4.
Article PubMed PubMed Central Google Scholar
Xue Y, Xu J, Li M, Gao Y. Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: triglyceride glucose index-related parameters. Front Endocrinol (Lausanne). 2022;13: 951689.
Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001–2018. Cardiovasc Diabetol. 2023;22(1):279.
Article PubMed PubMed Central Google Scholar
Reedy J, Lerman JL, Krebs-Smith SM, Kirkpatrick SI, Pannucci TE, Wilson MM, et al. Evaluation of the healthy eating index-2015. J Acad Nutr Diet. 2018;118(9):1622–33.
Article PubMed PubMed Central Google Scholar
Classification and Diagnosis of Diabetes. Standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15–33.
Quartagno M, Grund S, Carpenter JJRJ. Jomo: a flexible package for two-level joint modelling multiple imputation. R J. 2019;9(1):205.
D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the framingham heart study. Circulation. 2008;117(6):743–53.
Sánchez-Íñigo L, Navarro-González D, Fernández-Montero A, Pastrana-Delgado J, Martínez JA. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46(2):189–97.
Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. 2014;10(5):293–302.
Article CAS PubMed Google Scholar
Milicevic Z, Raz I, Beattie SD, Campaigne BN, Sarwat S, Gromniak E, et al. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia. Diabetes Care. 2008;31(Suppl 2):S155–60.
Article CAS PubMed Google Scholar
Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia-—and insulin-resistance-induced heart disease. Diabetologia. 2018;61(1):21–8.
Article CAS PubMed Google Scholar
Bigornia SJ, Farb MG, Tiwari S, Karki S, Hamburg NM, Vita JA, et al. Insulin status and vascular responses to weight loss in obesity. J Am Coll Cardiol. 2013;62(24):2297–305.
Article CAS PubMed Google Scholar
Stout RW, Bierman EL, Ross R. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res. 1975;36(2):319–27.
Article CAS PubMed Google Scholar
Dannecker C, Wagner R, Peter A, Hummel J, Vosseler A, Häring H-U, et al. Low-density lipoprotein cholesterol is associated with insulin secretion. J Clin Endocrinol Metab. 2021;106(6):1576–84.
Article PubMed PubMed Central Google Scholar
Limberg JK, Soares RN, Padilla J. Role of the autonomic nervous system in the hemodynamic response to hyperinsulinemia-implications for obesity and insulin resistance. Curr Diab Rep. 2022;22(4):169–75.
Article CAS PubMed PubMed Central Google Scholar
Lee S-H, Park S-Y, Choi CS. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab J. 2022;46(1):15–37.
Norton L, Shannon C, Gastaldelli A, DeFronzo RA. Insulin: the master regulator of glucose metabolism. Metabolism. 2022;129: 155142.
Article CAS PubMed Google Scholar
Buysschaert M, Medina JL, Bergman M, Shah A, Lonier J. Prediabetes and associated disorders. Endocrine. 2015;48(2):371–93.
Article CAS PubMed Google Scholar
Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007;30(3):753–9.
Article CAS PubMed Google Scholar
Lorenzo C, Hartnett S, Hanley AJ, Rewers MJ, Wagenknecht LE, Karter AJ, et al. Impaired fasting glucose and impaired glucose tolerance have distinct lipoprotein and apolipoprotein changes: the insulin resistance atherosclerosis study. J Clin Endocrinol Metab. 2013;98(4):1622–30.
Article CAS PubMed PubMed Central Google Scholar
Rooney MR, Fang M, Ogurtsova K, Ozkan B, Echouffo-Tcheugui JB, Boyko EJ, et al. Global prevalence of prediabetes. Diabetes Care. 2023;46(7):1388–94.
Article CAS PubMed Google Scholar
Cui J, Sun J, Wang W, Yasmeen N, Ke M, Xin H, et al. Triglycerides and total cholesterol concentrations in association with IFG/IGT in Chinese adults in Qingdao, China. BMC Public Health. 2018;18(1):444.
Article PubMed PubMed Central Google Scholar
Neves JS, Newman C, Bostrom JA, Buysschaert M, Newman JD, Medina JL, et al. Management of dyslipidemia and atherosclerotic cardiovascular risk in prediabetes. Diabetes Res Clin Pract. 2022;190: 109980.
Article CAS PubMed Google Scholar
Asgari S, Masrouri S, Khalili D, Azizi F, Hadaegh F. Differences in the impact of impaired glucose status on clinical outcomes in younger and older adults: over a decade of follow-up in the tehran lipid and glucose study. Front Cardiovasc Med. 2022;9:1018403.
Article PubMed PubMed Central Google Scholar
Oh M-R, Jung S-J, Bae E-J, Park B-H, Chae S-W. Clinical characteristics and associated risk factors of prediabetes in the southwestern region of korea from 2010–2019. J Clin Med. 2020;9(4):1114.
Article PubMed PubMed Central Google Scholar
Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, Martínez-Abundis E, Ramos-Zavala MG, Hernández-González SO, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–51.
Article CAS PubMed Google Scholar
Lee SB, Ahn CW, Lee BK, Kang S, Nam JS, You JH, et al. Association between triglyceride glucose index and arterial stiffness in Korean adults. Cardiovasc Diabetol. 2018;17(1):41.
Comments (0)